Y Hirsch-Moverman1, R Shrestha-Kuwahara2, J Bethel3, H M Blumberg4, T K Venkatappa5, C R Horsburgh6, P W Colson1. 1. Charles P Felton National Tuberculosis Center, ICAP, Mailman School of Public Health, Columbia University, New York City, New York, USA. 2. Centers for Disease Control and Prevention, Atlanta, Georgia, USA. 3. Westat, Rockville, Maryland, USA. 4. Division of Infectious Diseases, Department of Medicine, Emory University, Atlanta, Georgia, USA. 5. Hawaii Department of Health, Hawaii, USA. 6. Boston University School of Public Health, Boston, Massachusetts, USA.
Abstract
OBJECTIVES: To assess latent tuberculous infection (LTBI) treatment completion rates in a large prospective US/Canada multisite cohort and identify associated risk factors. METHODS: This prospective cohort study assessed factors associated with LTBI treatment completion through interviews with persons who initiated treatment at 12 sites. Interviews were conducted at treatment initiation and completion/cessation. Participants received usual care according to each clinic's procedure. Multivariable models were constructed based on stepwise assessment of potential predictors and interactions. RESULTS: Of 1515 participants initiating LTBI treatment, 1323 had information available on treatment completion; 617 (46.6%) completed treatment. Baseline predictors of completion included male sex, foreign birth, not thinking it would be a problem to take anti-tuberculosis medication, and having health insurance. Participants in stable housing who received monthly appointment reminders were more likely to complete treatment than those without stable housing or without monthly reminders. End-of-treatment predictors of non-completion included severe symptoms and the inconvenience of clinic/pharmacy schedules, barriers to care and changes of residence. Common reasons for treatment non-completion were patient concerns about tolerability/toxicity, appointment conflicts, low prioritization of TB, and forgetfulness. CONCLUSIONS: Less than half of treatment initiators completed treatment in our multisite study. Addressing tangible issues such as not having health insurance, toxicity concerns, and clinic accessibility could help to improve treatment completion rates.
OBJECTIVES: To assess latent tuberculous infection (LTBI) treatment completion rates in a large prospective US/Canada multisite cohort and identify associated risk factors. METHODS: This prospective cohort study assessed factors associated with LTBI treatment completion through interviews with persons who initiated treatment at 12 sites. Interviews were conducted at treatment initiation and completion/cessation. Participants received usual care according to each clinic's procedure. Multivariable models were constructed based on stepwise assessment of potential predictors and interactions. RESULTS: Of 1515 participants initiating LTBI treatment, 1323 had information available on treatment completion; 617 (46.6%) completed treatment. Baseline predictors of completion included male sex, foreign birth, not thinking it would be a problem to take anti-tuberculosis medication, and having health insurance. Participants in stable housing who received monthly appointment reminders were more likely to complete treatment than those without stable housing or without monthly reminders. End-of-treatment predictors of non-completion included severe symptoms and the inconvenience of clinic/pharmacy schedules, barriers to care and changes of residence. Common reasons for treatment non-completion were patient concerns about tolerability/toxicity, appointment conflicts, low prioritization of TB, and forgetfulness. CONCLUSIONS: Less than half of treatment initiators completed treatment in our multisite study. Addressing tangible issues such as not having health insurance, toxicity concerns, and clinic accessibility could help to improve treatment completion rates.
Authors: Fred K Shieh; Graham Snyder; C Robert Horsburgh; John Bernardo; Claire Murphy; Jussi J Saukkonen Journal: Am J Respir Crit Care Med Date: 2006-06-29 Impact factor: 21.405
Authors: Timothy R Sterling; James Bethel; Stefan Goldberg; Paul Weinfurter; Lourdes Yun; C Robert Horsburgh Journal: Am J Respir Crit Care Med Date: 2006-01-19 Impact factor: 21.405
Authors: Diane E Bennett; Jeanne M Courval; Ida Onorato; Tracy Agerton; Judy D Gibson; Lauren Lambert; Geraldine M McQuillan; Brenda Lewis; Thomas R Navin; Kenneth G Castro Journal: Am J Respir Crit Care Med Date: 2007-11-07 Impact factor: 21.405
Authors: P W Colson; Y Hirsch-Moverman; J Bethel; P Vempaty; K Salcedo; K Wall; W Miranda; S Collins; C R Horsburgh Journal: Int J Tuberc Lung Dis Date: 2013-04 Impact factor: 2.373
Authors: U Mack; G B Migliori; M Sester; H L Rieder; S Ehlers; D Goletti; A Bossink; K Magdorf; C Hölscher; B Kampmann; S M Arend; A Detjen; G Bothamley; J P Zellweger; H Milburn; R Diel; P Ravn; F Cobelens; P J Cardona; B Kan; I Solovic; R Duarte; D M Cirillo Journal: Eur Respir J Date: 2009-05 Impact factor: 16.671
Authors: C Robert Horsburgh; Stefan Goldberg; James Bethel; Shande Chen; Paul W Colson; Yael Hirsch-Moverman; Stephen Hughes; Robin Shrestha-Kuwahara; Timothy R Sterling; Kirsten Wall; Paul Weinfurter Journal: Chest Date: 2009-09-30 Impact factor: 9.410
Authors: Pierre J Plourde; Christopher A Basham; Shelley Derksen; Jennifer Schultz; Scott McCulloch; Linda Larcombe; Kathi Avery Kinew; Lisa M Lix Journal: Can J Public Health Date: 2019-07-11
Authors: Yecai Liu; Christina R Phares; Drew L Posey; Susan A Maloney; Kevin P Cain; Michelle S Weinberg; Kristine M Schmit; Nina Marano; Martin S Cetron Journal: Ann Am Thorac Soc Date: 2020-11
Authors: Robert Belknap; David Holland; Pei-Jean Feng; Joan-Pau Millet; Joan A Caylà; Neil A Martinson; Alicia Wright; Michael P Chen; Ruth N Moro; Nigel A Scott; Bert Arevalo; José M Miró; Margarita E Villarino; Marc Weiner; Andrey S Borisov Journal: Ann Intern Med Date: 2017-11-07 Impact factor: 25.391
Authors: Melissa Bauer; Sara Ahmed; Andrea Benedetti; Christina Greenaway; Marek Lalli; Allison Leavens; Dick Menzies; Claudia Vadeboncoeur; Bilkis Vissandjée; Ashley Wynne; Kevin Schwartzman Journal: Health Qual Life Outcomes Date: 2015-05-27 Impact factor: 3.186